Find FREEDOM with the power of two
The FREEDOM-1 and FREEDOM-2 clinical trials are researching a different way to treat patients without immunosuppressive medicines after a living donor kidney transplant.
If you recently had a kidney transplant or are planning on receiving one from a living donor soon, take a short survey to find out if you could qualify.
The FREEDOM clinical trials
Both clinical trials are studying the safety and efficacy of an investigational cell therapy called FCR001. It is an investigational stem and immune cell-based product that comes from the kidney donor’s blood.
FREEDOM-1 clinical trial
The FREEDOM-1 clinical trial is for people who will receive a kidney transplant from a living donor.
FREEDOM-2 clinical trial
The FREEDOM-2 clinical trial is for people who have already received a kidney transplant from a living donor within the last 3 to 12 months.
What is the purpose of these trials?
The FREEDOM trials will help us assess the safety and efficacy of an investigational cell therapy called FCR001.
Who can participate?
We are looking for people who recently had a kidney transplant or are planning on receiving one from a living donor soon.
How long are these trials?
All recipients—in both trials—will have regular study visits for about five years.
Could you take part?
If you and your donor meet the eligibility criteria, you may qualify.
Take a short survey to find out.
